MYLERAN K2A (Myleran 2 MG)
Generic Name: busulfan
Pill imprint MYLERAN K2A has been identified as Myleran 2 MG.
Myleran is used in the treatment of bone marrow transplantation; chronic myelogenous leukemia; thrombocythemia and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Myleran 2 MG is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- busulfan
- Imprint:
- MYLERAN K2A
- Strength:
- 2 MG
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Alkylating agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- GLAXO SMITH KLINE
- National Drug Code (NDC):
- 00173-0713
- Inactive Ingredients:
- hypromelloses
lactose anhydrous
magnesium stearate
corn starch
triacetin
titanium dioxide
More about Myleran (busulfan)
Consumer resources
- Other brands: Busulfex
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
